Financhill
Buy
65

BLFY Quote, Financials, Valuation and Earnings

Last price:
$12.74
Seasonality move :
-9.85%
Day range:
$12.65 - $12.78
52-week range:
$7.61 - $13.13
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
2.74x
P/B ratio:
0.84x
Volume:
155.2K
Avg. volume:
287.8K
1-year change:
29.08%
Market cap:
$264.5M
Revenue:
$87.2M
EPS (TTM):
-$0.46

BLFY Analysts' Consensus Rating

The 1 analyst providing 12-month price projections for Blue Foundry Bancorp shares anticipate an average target of $10.00, ranging from a low estimate of $10.00 to a high estimate of $10.00. This average target implies a growth of -21.51% compared to the current stock price of $12.74.

Consensus Price Target

$10.00

Highest Price Target

$10.00

Lowest Price Target

$10.00

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Analyst Ratings

6M Ago 1M Ago Current
Buy 0 0 0

Hold 2 1 1

Sell 0 0 0
Consensus Hold Hold Hold

BLFY Recommendation Trends

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Stock Ideas

Buy
57
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy
55
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
80
TVTX alert for Dec 26

Travere Therapeutics, Inc. [TVTX] is down 0.32% over the past day.

Buy
64
ZCSH alert for Dec 26

Grayscale Zcash Trust (ZEC) [ZCSH] is down 1.79% over the past day.

Buy
66
ASTS alert for Dec 26

AST Spacemobile, Inc. [ASTS] is down 6.09% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock